183
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

The Correlation Between Biofilm-Forming Ability of Community-Acquired Methicillin-Resistant Staphylococcus aureus Isolated from the Respiratory Tract and Clinical Characteristics in Children

ORCID Icon, , , , , ORCID Icon, & ORCID Icon show all
Pages 3657-3668 | Published online: 12 Jul 2022

References

  • Lakhundi S, Zhang K. Methicillin-resistant staphylococcus aureus: molecular characterization, evolution, and epidemiology. Clin Microbiol Rev. 2018;31(4):e00020–18. doi:10.1128/CMR.00020-18
  • Elston DM. Community-acquired methicillin-resistant Staphylococcus aureus. J Am Acad Dermatol. 2007;56(1):1–16;quiz 17–20. doi:10.1016/j.jaad.2006.04.018
  • Saravolatz LD, Markowitz N, Arking L, et al. Methicillin-resistant Staphylococcus aureus. Epidemiologic observations during a community-acquired outbreak. Ann Intern Med. 1982;96(1):11–16. doi:10.7326/0003-4819-96-1-11
  • Mediavilla JR, Chen L, Mathema B, et al. Global epidemiology of community-associated methicillin resistant Staphylococcus aureus (CA-MRSA). Curr Opin Microbiol. 2012;15(5):588–595. doi:10.1016/j.mib.2012.08.003
  • Nimmo GR. USA300 abroad: global spread of a virulent strain of community-associated methicillin-resistant Staphylococcus aureus. Clin Microbiol Infect. 2012;18(8):725–734. doi:10.1111/j.1469-0691.2012.03822.x
  • David MZ, Daum RS. Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clin Microbiol Rev. 2010;23(3):616–687. doi:10.1128/CMR.00081-09
  • Loewen K, Schreiber Y, Kirlew M, et al. Community-associated methicillin-resistant Staphylococcus aureus infection: literature review and clinical update. Can Fam Physician. 2017;63(7):512–520.
  • Liao F, Gu W, Fu X, et al. Comparison of virulence-related determinants between the ST59-t437 and ST239-t030 genotypes of methicillin-resistant Staphylococcus aureus. BMC Microbiol. 2021;21(1):264. doi:10.1186/s12866-021-02329-5
  • Naimi TS, LeDell KH, Como-Sabetti K, et al. Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA. 2003;290(22):2976–2984. doi:10.1001/jama.290.22.2976
  • Song JH, Hsueh PR, Chung DR, et al. Spread of methicillin-resistant Staphylococcus aureus between the community and the hospitals in Asian countries: an ANSORP study. J Antimicrob Chemother. 2011;66(5):1061–1069. doi:10.1093/jac/dkr024
  • Centers for Disease C, Prevention. Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus - Minnesota and North Dakota, 1997–1999. MMWR Morb Mortal Wkly Rep. 1999;48(32):707–710.
  • Nazzari E, Torretta S, Pignataro L, et al. Role of biofilm in children with recurrent upper respiratory tract infections. Eur J Clin Microbiol Infect Dis. 2015;34(3):421–429. doi:10.1007/s10096-014-2261-1
  • Boisvert AA, Cheng MP, Sheppard DC, et al. Microbial biofilms in pulmonary and critical care diseases. Ann Am Thorac Soc. 2016;13(9):1615–1623. doi:10.1513/AnnalsATS.201603-194FR
  • Tsai MS, Chen CJ, Lin TY, et al. Nasal methicillin-resistant Staphylococcus aureus colonization among otherwise healthy children aged between 2 months and 5 years in northern Taiwan, 2005–2010. J Microbiol Immunol Infect. 2018;51(6):756–762. doi:10.1016/j.jmii.2017.07.014
  • Liang B, Liang X, Gao F, et al. Active surveillance, drug resistance, and genotypic profiling of staphylococcus aureus among school-age children in China. Front Med. 2021;8:701494. doi:10.3389/fmed.2021.701494
  • Gesualdo F, Bongiorno D, Rizzo C, et al. MRSA nasal colonization in children: prevalence meta-analysis, review of risk factors and molecular genetics. Pediatr Infect Dis J. 2013;32(5):479–485. doi:10.1097/INF.0b013e3182864e4c
  • Lin J, Peng Y, Xu P, et al. Methicillin-resistant staphylococcus aureus nasal colonization in Chinese children: a prevalence meta-analysis and review of influencing factors. PLoS One. 2016;11(7):e0159728. doi:10.1371/journal.pone.0159728
  • Hisata K, Kuwahara-Arai K, Yamanoto M, et al. Dissemination of methicillin-resistant staphylococci among healthy Japanese children. J Clin Microbiol. 2005;43(7):3364–3372. doi:10.1128/JCM.43.7.3364-3372.2005
  • Aj K, Mu Y, Bulens S, et al. Health care-associated invasive MRSA infections, 2005–2008. JAMA. 2010;304(6):641–648. doi:10.1001/jama.2010.1115
  • Harmsen D, Claus H, Witte W, et al. Typing of methicillin-resistant Staphylococcus aureus in a university hospital setting by using novel software for spa repeat determination and database management. J Clin Microbiol. 2003;41(12):5442–5448. doi:10.1128/JCM.41.12.5442-5448.2003
  • McClure JA, Conly JM, Lau V, et al. Novel multiplex PCR assay for detection of the staphylococcal virulence marker Panton-Valentine leukocidin genes and simultaneous discrimination of methicillin-susceptible from -resistant staphylococci. J Clin Microbiol. 2006;44(3):1141–1144. doi:10.1128/JCM.44.3.1141-1144.2006
  • O’Toole GA. Microtiter dish biofilm formation assay. J Vis Exp. 2011;(47). doi:10.3791/2437
  • Ghasemian A, Najar Peerayeh S, Bakhshi B, et al. Comparison of biofilm formation between methicillin-resistant and methicillin-susceptible isolates of Staphylococcus aureus. Iran Biomed J. 2016;20(3):175–181. doi:10.7508/ibj.2016.03.007
  • Cha JO, Park YK, Lee YS, et al. In vitro biofilm formation and bactericidal activities of methicillin-resistant Staphylococcus aureus clones prevalent in Korea. Diagn Microbiol Infect Dis. 2011;70(1):112–118. doi:10.1016/j.diagmicrobio.2010.11.018
  • Stepanovic S, Vukovic D, Hola V, et al. Quantification of biofilm in microtiter plates: overview of testing conditions and practical recommendations for assessment of biofilm production by staphylococci. APMIS. 2007;115(8):891–899. doi:10.1111/j.1600-0463.2007.apm_630.x
  • Kaplan SL. Implications of methicillin-resistant Staphylococcus aureus as a community-acquired pathogen in pediatric patients. Infect Dis Clin North Am. 2005;19(3):747–757. doi:10.1016/j.idc.2005.05.011
  • McAdams RM, Mazuchowski E, Ellis MW, et al. Necrotizing staphylococcal pneumonia in a neonate. J Perinatol. 2005;25(10):677–679. doi:10.1038/sj.jp.7211364
  • Al-Tawfiq JA. Father-to-infant transmission of community-acquired methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit. Infect Control Hosp Epidemiol. 2006;27(6):636–637. doi:10.1086/505097
  • Sax H, Posfay-Barbe K, Harbarth S, et al. Control of a cluster of community-associated, methicillin-resistant Staphylococcus aureus in neonatology. J Hosp Infect. 2006;63(1):93–100. doi:10.1016/j.jhin.2005.11.016
  • Hollis RJ, Barr JL, Doebbeling BN, et al. Familial carriage of methicillin-resistant Staphylococcus aureus and subsequent infection in a premature neonate. Clin Infect Dis. 1995;21(2):328–332. doi:10.1093/clinids/21.2.328
  • David MD, Kearns AM, Gossain S, et al. Community-associated meticillin-resistant Staphylococcus aureus: nosocomial transmission in a neonatal unit. J Hosp Infect. 2006;64(3):244–250. doi:10.1016/j.jhin.2006.06.022
  • Saunders A, Panaro L, McGeer A, et al. A nosocomial outbreak of community-associated methicillin-resistant Staphylococcus aureus among healthy newborns and postpartum mothers. Can J Infect Dis Med Microbiol. 2007;18(2):128–132. doi:10.1155/2007/617526
  • Rutar T. Vertically acquired community methicillin-resistant Staphylococcus aureus dacryocystitis in a neonate. J AAPOS. 2009;13(1):79–81. doi:10.1016/j.jaapos.2008.08.005
  • Gastelum DT, Dassey D, Mascola L, et al. Transmission of community-associated methicillin-resistant Staphylococcus aureus from breast milk in the neonatal intensive care unit. Pediatr Infect Dis J. 2005;24(12):1122–1124. doi:10.1097/01.inf.0000189983.71585.30
  • Mean M, Mallaret MR, Andrini P, et al. A neonatal specialist with recurrent methicillin-resistant Staphylococcus aureus (MRSA) carriage implicated in the transmission of MRSA to newborns. Infect Control Hosp Epidemiol. 2007;28(5):625–628. doi:10.1086/513616
  • Cho SY, Chung DR. Infection prevention strategy in hospitals in the era of community-associated methicillin-resistant Staphylococcus aureus in the Asia-Pacific Region: a review. Clin Infect Dis. 2017;64(suppl_2):S82–S90. doi:10.1093/cid/cix133
  • Chen Y, Sun L, Ba X, et al. Epidemiology, evolution and cryptic susceptibility of methicillin-resistant Staphylococcus aureus in China: a whole-genome-based survey. Clin Microbiol Infect. 2022;28(1):85–92. doi:10.1016/j.cmi.2021.05.024
  • Chen H, Yin Y, van Dorp L, et al. Drivers of methicillin-resistant Staphylococcus aureus (MRSA) lineage replacement in China. Genome Med. 2021;13(1):171. doi:10.1186/s13073-021-00992-x
  • Buescher ES. Community-acquired methicillin-resistant Staphylococcus aureus in pediatrics. Curr Opin Pediatr. 2005;17(1):67–70. doi:10.1097/01.mop.0000147906.30720.4d
  • Chua K, Laurent F, Coombs G, et al. Antimicrobial resistance: not community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA)! A clinician’s guide to community MRSA - its evolving antimicrobial resistance and implications for therapy. Clin Infect Dis. 2011;52(1):99–114. doi:10.1093/cid/ciq067
  • Copin R, Sause WE, Fulmer Y, et al. Sequential evolution of virulence and resistance during clonal spread of community-acquired methicillin-resistant Staphylococcus aureus. Proc Natl Acad Sci U S A. 2019;116(5):1745–1754. doi:10.1073/pnas.1814265116
  • Desroches M, Potier J, Laurent F, et al. Prevalence of mupirocin resistance among invasive coagulase-negative staphylococci and methicillin-resistant Staphylococcus aureus (MRSA) in France: emergence of a mupirocin-resistant MRSA clone harbouring mupA. J Antimicrob Chemother. 2013;68(8):1714–1717. doi:10.1093/jac/dkt085
  • Sievert DM, Rudrik JT, Patel JB, et al. Vancomycin-resistant Staphylococcus aureus in the United States, 2002–2006. Clin Infect Dis. 2008;46(5):668–674. doi:10.1086/527392
  • Linares J. The VISA/GISA problem: therapeutic implications. Clin Microbiol Infect. 2001;7(Suppl 4):8–15. doi:10.1046/j.1469-0691.2001.00054.x
  • Hamilos DL. Biofilm formations in pediatric respiratory tract infection: part 1: biofilm structure, role of innate immunity in protection against and response to biofilm, methods of biofilm detection, pediatric respiratory tract diseases associated with mucosal biofilm formation. Curr Infect Dis Rep. 2019;21(2):6. doi:10.1007/s11908-019-0658-9
  • Graf AC, Leonard A, Schauble M, et al. Virulence factors produced by Staphylococcus aureus biofilms have a moonlighting function contributing to biofilm integrity. Mol Cell Proteomics. 2019;18(6):1036–1053. doi:10.1074/mcp.RA118.001120
  • Lei MG, Gupta RK, Lee CY. Proteomics of Staphylococcus aureus biofilm matrix in a rat model of orthopedic implant-associated infection. PLoS One. 2017;12(11):e0187981. doi:10.1371/journal.pone.0187981
  • Ebner P, Rinker J, Nguyen MT, et al. Excreted cytoplasmic proteins contribute to pathogenicity in Staphylococcus aureus. Infect Immun. 2016;84(6):1672–1681. doi:10.1128/IAI.00138-16
  • Campoccia D, Montanaro L, Arciola CR. Extracellular DNA (eDNA). A major ubiquitous element of the bacterial biofilm architecture. Int J Mol Sci. 2021;22(16):9100. doi:10.3390/ijms22169100
  • Karygianni L, Ren Z, Koo H, et al. Biofilm matrixome: extracellular components in structured microbial communities. Trends Microbiol. 2020;28(8):668–681. doi:10.1016/j.tim.2020.03.016
  • Tan NC, Foreman A, Jardeleza C, et al. The multiplicity of Staphylococcus aureus in chronic rhinosinusitis: correlating surface biofilm and intracellular residence. Laryngoscope. 2012;122(8):1655–1660. doi:10.1002/lary.23317
  • Jardeleza C, Miljkovic D, Baker L, et al. Inflammasome gene expression alterations in Staphylococcus aureus biofilm-associated chronic rhinosinusitis. Rhinology. 2013;51(4):315–322. doi:10.4193/Rhino13.045
  • Yin W, Xu S, Wang Y, et al. Ways to control harmful biofilms: prevention, inhibition, and eradication. Crit Rev Microbiol. 2021;47(1):57–78. doi:10.1080/1040841X.2020.1842325
  • Ribeiro SM, Felicio MR, Boas EV, et al. New frontiers for anti-biofilm drug development. Pharmacol Ther. 2016;160:133–144. doi:10.1016/j.pharmthera.2016.02.006
  • Xu Y, Jones JE, Yu H, et al. Nanoscale plasma coating inhibits formation of Staphylococcus aureus biofilm. Antimicrob Agents Chemother. 2015;59(12):7308–7315. doi:10.1128/AAC.01944-15
  • Penesyan A, Paulsen IT, Gillings MR, et al. Secondary effects of antibiotics on microbial biofilms. Front Microbiol. 2020;11:2109. doi:10.3389/fmicb.2020.02109
  • Lebeaux D, Ghigo JM, Beloin C. Biofilm-related infections: bridging the gap between clinical management and fundamental aspects of recalcitrance toward antibiotics. Microbiol Mol Biol Rev. 2014;78(3):510–543. doi:10.1128/MMBR.00013-14